Table 1.
Demographic and clinical traits for all participants.
| Characteristic | PDM (n = 41) | HC (n = 39) | T or χ2 | p |
|---|---|---|---|---|
| Age | 22.17 ± 2.73 | 22.92 ± 1.83 | −1.44 | 0.153 |
| VAS (days 10–14) | 0 | 0 | – | – |
| SAS (days 10–14) | 38.21 ± 6.39 | 35.85 ± 5.13 | 1.81 | 0.07 |
| SDS (days 10–14) | 39.54 ± 6.84 | 37.00 ± 6.28 | 1.72 | 0.09 |
| PGE2 (days 1–3) | 542.63 ± 225.34 | – | – | – |
| PGF2α (days 1–3) | 732.60 ± 121.10 | – | – | – |
PDM: primary dysmenorrhea; HC: healthy control; VAS: visual analog scale; SAS: self-rating anxiety scale; SDS: self-rating depression scale; PGE2: prostaglandin E2; PGF2α: prostaglandin F2 alpha.